|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,601 GBX | -0.23% |
|
-1.50% | +10.64% |
| 13/06 | REGENXBIO Inc. Announces Chief Executive Officer Changes | CI |
| 12/06 | Moderna's RSV Vaccine Has 'Ample Opportunity' Despite Seasoned Competitors, Oppenheimer Says | MT |
Elegen Corporation announced that it will receive $35,982,969 in funding on May 9, 2024. The company will issue common stock in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 1,601 GBX | -0.23% | -1.50% | 8.3TCr | ||
| 129.8 USD | -0.55% | -2.35% | 3.79TCr | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +10.64% | 8.3TCr | |
| +41.96% | 63TCr | |
| -7.15% | 35TCr | |
| +18.77% | 33TCr | |
| +8.79% | 30TCr | |
| +18.02% | 25TCr | |
| +1.27% | 22TCr | |
| +11.95% | 22TCr | |
| +3.68% | 16TCr | |
| -4.38% | 16TCr |
GSK PLC 
